ChartMill assigns a Buy % Consensus number of 80% to CYTK. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2025-10-06 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-02 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-09-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-22 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-09-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-03 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-03 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-09-02 | Needham | Reiterate | Buy -> Buy |
| 2025-09-02 | Stifel | Maintains | Buy -> Buy |
| 2025-09-02 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-08 | Citigroup | Maintains | Buy -> Buy |
| 2025-06-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-29 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-05-14 | Needham | Reiterate | Buy -> Buy |
| 2025-05-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-05-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-07 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-02 | Needham | Reiterate | Buy -> Buy |
| 2025-04-24 | Barclays | Initiate | Overweight |
| 2025-04-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-15 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-04-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-04-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-03 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
26 analysts have analysed CYTK and the average price target is 81.15 USD. This implies a price increase of 26.53% is expected in the next year compared to the current price of 64.13.
The consensus rating for CYTOKINETICS INC (CYTK) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CYTOKINETICS INC (CYTK) is 26.